Topic

Crysvita (burosumab)

A collection of 44 issues

How to Get Crysvita (burosumab) Covered by Cigna in North Carolina: Appeals Guide & Templates

Answer Box: Getting Crysvita (burosumab) Covered by Cigna in North Carolina For Medicare Advantage: Crysvita requires no prior authorization when billed under Medical Oncology (HCPCS J0584). For Commercial plans: Prior authorization is required with specific XLH or TIO diagnosis documentation, phosphate monitoring plan, and specialist oversight. If denied, appeal internally

Crysvita (Burosumab) Approval with UnitedHealthcare in New York: Complete Guide to Prior Authorization, Appeals, and Coverage

Answer Box: Getting Crysvita Covered by UnitedHealthcare in New York UnitedHealthcare covers Crysvita (burosumab) for X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia (TIO) with prior authorization in New York. Key requirements include confirmed diagnosis via genetic testing or elevated FGF23, specialist prescribing, and documented clinical need. First step today: Contact your

Get Crysvita (Burosumab) Covered by UnitedHealthcare in Florida: Complete Decision Tree & Appeal Guide

Quick Answer: Do You Qualify for Crysvita Coverage? Yes, if you have: Confirmed X-linked hypophosphatemia (XLH) or tumor-induced osteomalacia (TIO), genetic/biochemical testing showing PHEX mutations or elevated FGF23, specialist prescription, and serum phosphorus below normal range. First step: Have your endocrinologist submit prior authorization through UnitedHealthcare's provider

How to Get Crysvita (burosumab) Covered by Blue Cross Blue Shield in Ohio: Prior Authorization, Appeals & Step Therapy Guide

Answer Box: Getting Crysvita Covered in Ohio Blue Cross Blue Shield Ohio requires prior authorization for Crysvita (burosumab), with step therapy requiring failure of oral phosphate and vitamin D first. Coverage is restricted to FDA-approved uses (X-linked hypophosphatemia and tumor-induced osteomalacia) with specialist prescription. If denied, you have 180 days